INT81955
From wiki-pain
|
|
|
|
|
Sentences Mentioned In
Key: | Protein | Mutation | Event | Anatomy | Negation | Speculation | Pain term | Disease term |
All mutations which have been identified as a cause of HSN I are summarised in the Mutation Database of Inherited Peripheral Neuropathies [20]. | |||||||||||||||
| |||||||||||||||
|
Large families in which mutations in SPTLC1 and RAB7 are excluded can be used for genome wide linkage studies to detect a novel HSN I locus or to confirm linkage to the third known HSN I locus (i.e. the HSN IB locus). | |||||||||||||||
| |||||||||||||||
|
Despite the late onset of the disease, the progressive course, and the lancinating pain, the terminal features of this patient, which involved a selective loss of myelinated fibers and widespread sensory loss, seem to be symptomatic of HSAN II, the progressive form of autosomal recessive sensory neuropathy, and emphasize the clinical heterogeneity of HSAN. | |||||||||||||||
| |||||||||||||||
|
HSAN IV is caused by mutations in the NTRK1 (TRKA) gene that is located on chromosome 1 (1q21-q22). | |||||||||||||||
| |||||||||||||||
|
The C133W and V144D SPTLC1 mutations were originally suggested to increase the serine palmitoyltransferase function with higher levels of glycosyl ceramide compared to controls behaving as gain of function mutations [13]. | |||||||||||||||
| |||||||||||||||
|
Foot deformity promotes ulcerations and skin changes such as hyperkeratosis at pressure points, which is also often prominent in HSN I. | |||||||||||||||
| |||||||||||||||
|
Comparing the kinetics between mutant and wildtype SPT showed that both forms have similar Km's for serine and alanine but that Vmax for alanine is greatly increased in the HSAN1 mutants [12]. | |||||||||||||||
| |||||||||||||||
|
HSN1 is caused by mutations in the gene, encoding the long chain base 1 of serine palmitoyltransferase (SPT) [Nat. | |||||||||||||||
| |||||||||||||||
|
The inherited neuropathy HSAN1 is caused by a pathological overproduction of DSBs due to several missense mutations in SPT [4]. | |||||||||||||||
| |||||||||||||||
|
This promiscuous activity is greatly increased in the case of the sensory neuropathy HSAN1, and pathologically elevated DSB levels have been identified as the cause of this disease. | |||||||||||||||
| |||||||||||||||
|
This observation is consistent with the hypothesis that HSAN1 is the result of a gain-of-function mutation in SPTLC1 that leads to accumulation of a toxic metabolite. | |||||||||||||||
| |||||||||||||||
|
CONCLUSION: SSR provides another parameter to improve differentiation of HSAN III from HSAN IV, and also gives us additional information regarding sympathetic sudomotor fiber function in these developmental diseases.
| |||||||||||||||
| |||||||||||||||
|
CONCLUSION: SSR provides another parameter to improve differentiation of HSAN III from HSAN IV, and also gives us additional information regarding sympathetic sudomotor fiber function in these developmental diseases.
| |||||||||||||||
| |||||||||||||||
|
Mutations in this gene are known to be responsible for HSAN IV (congenital insensitivity to pain with anhidrosis). | |||||||||||||||
| |||||||||||||||
|
General Comments
This test has worked.